Mallon Mark 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 2, 2020
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Class A Common Stock
2020-02-27+221,061→ 524,486 total
Footnotes (1)
- [F1]The restricted stock unit award, granted as an annual performance award, vests as to approximately 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.